Biochemical Markers for Alzheimer’s and Parkinson’s Disease
Journal: Austin Journal of Clinical Neurology (Vol.2, No. 7)Publication Date: 2015-06-30
Authors : Farías GA; Arata L; Guzm;
Page : 1-9
Keywords : Biomarkers; Alzheimer`s Disease; Parkinson`s Disease; Protein misfolding diseases;
Abstract
Many biomarkers are currently being searched in neurodegenerative diseases like Alzheimer’s disease and Parkinson’s disease. These diseases share some common pathophysiological mechanisms and the presence of protein aggregates. Measurements of those proteins -like tau, amyloid-beta peptide and α-synuclein-, as well other mediators of neurodegeneration in cerebrospinal fluid and peripheral fluids have been explored as biomarkers. Here we summarize some of the available data on biochemical markers for neurodegenerative diseases, considering advantages and drawbacks of each marker and method of analysis.
Other Latest Articles
- Category Specificity, Alzheimer Disease and Normative Studies: A Review and Several Recent Instruments for Spanish Speakers
- RESOURCE AWARE AND RELIABLE CLUSTER BASED COMMUNICATION SCHEME FOR WIRELESS BODY AREA NETWORK USING GENETIC ALGORITHM
- Narcissism Vulnerability as Risk Factor for Alzheimer´s Disease- A Prospective Study
- DETECTION AND PREVENTION METHOD OF ROOTING ATTACK ON THE ANDROID PHONES
- AUDIO - VIDEO STEGANOGRAPHY USING FORENSIC TECHNIQUEFOR DATA SECURITY
Last modified: 2016-08-09 21:26:43